Skip to main content

National HealthCare Corporation (NHC) Stock Analysis

Breakout setup

SellVALUE-TRAP 1/5High Confidence

Healthcare · Medical Care Facilities

Sell if holding. Multiple concerning factors at $171.50: Concentration risk — Supplier: National Health Investors master lease; Earnings expected to decline ~94% (cyclical peak).

National HealthCare Corporation operates 80 skilled nursing facilities, 26 assisted living, 9 independent living, 3 behavioral health hospitals, and 67 homecare/hospice agencies in 9 states, primarily in the Southeast and Midwest US. Net patient revenues represent 96.8% of... Read more

$171.50+5.3% A.UpsideScore 4.9/10#21 of 27 Medical Care Facilities
Stop $159.28Target $180.40(resistance)A.R:R 0.0:1

Sell if holding. Multiple concerning factors at $171.50: Concentration risk — Supplier: National Health Investors master lease; Earnings expected to decline ~94% (cyclical peak). Chart setup: Golden cross, above all MAs, RSI 50, MACD bullish. Score 4.9/10, high confidence.

Passes 5/7 gates (positive momentum, clean insider activity, no SEC red flags, news events none recent, semi cycle peak clear). Suitability: aggressive.

Thesis

Rewards
No bull case signals
Risks
Concentration risk — Supplier: National Health Investors master lease
Earnings expected to decline ~94% (cyclical peak)
Leverage penalty (D/E 8.1): -1.5

Key Metrics

P/E (TTM)22.8
P/E (Fwd)407.1
Mkt Cap$2.7B
EV/EBITDA14.8
Profit Mgn7.9%
ROE11.9%
Rev Growth4.6%
Beta0.59
Dividend1.46%
Rating analysts

Quality Signals

Piotroski F8/9

Options Flow

P/C0.03bullish
IV45%normal
Max Pain$155-9.6% vs spot

Concentration Risks(10-K Item 1A)

  • HIGHSupplierNational Health Investors master lease
    10-K Item 1A: 'A significant portion of our skilled nursing and independent living facilities are subject to a long-term Master Agreement to Lease with National Health Investors, Inc.'

Material Events(8-K, last 90d)

  • 2026-04-22Item 1.01MEDIUM
    NHC/OP L.P. entered Purchase and Sale Agreement with NHI on April 21, 2026 to acquire 32 SNFs and 3 ILFs currently under the Master Lease for $560 million; no financing contingencies.
    SEC filing →
  • 2026-02-17Item 5.02LOW
    NHC Board appointed Dr. David Gifford and Andrew Adams as directors effective February 12, 2026, expanding Board to 9 directors. No predecessor departures cited.
    SEC filing →

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. Full disclaimer

Rating Breakdown

3 floor-breakers

Ranks in the bottom of its industry peers on the composite signal. Better names in the same sector exist.static

Value Rank
2.4
Growth Rank
3.1
Quality Rank
5.8

Growth below the gate floor. Component breakdown shows what dragged the score down.static

Revenue Growth
3.7
Low model confidence on this dimension (33%).

No near-term catalyst priced in. Thesis progression will come from fundamentals grinding, not event reaction.static

Earnings History
0.0
Surprise Avg
0.0
Earnings Timing
5.0
Dividend
10.0
Earnings concerns: 0B/4MEarnings in 8 daysDividend: 146.0%
GatesA.R:R UPSIDE_EXHAUSTED (upside=0.0%)EARNINGS PROXIMITY 8d<=14d (soft)Momentum 6.9>=5.5Insider activity: OKNo SEC red flagsNEWS EVENTS NONE RECENTSEMI CYCLE PEAK CLEARBreakoutSuitability: Aggressive
RSI
50 · Neutral
20D MA 50D MA 200D MAGOLDEN CROSSSupport $154.91Resistance $184.08

Price Targets

$159
$180
A.Upside+5.2%
A.R:R0.0:1

Position Sizing

ConvictionNone
Suggested %0.5%
Max %1%
RegimeCautious

Risk Alerts

! Cyclical trap - fwd PE 407x vs trail 23x (17.8x)

Earnings

M
M
M
M
0/4 beats
Next Earnings2026-05-08 (8d)

Verdict History

reverse chrono — latest first
Loading history...
Verdicts are recorded on every nightly pipeline run. Rows capture transitions (verdict flips, score deltas ≥0.3, entry/TP/SL changes). Rows with a ▶ can be expanded to see the change reason. Aggregate cohort performance is tracked in the recommendation ledger.
Frequently Asked Questions
Is NHC stock a buy right now?

Sell if holding. Multiple concerning factors at $171.50: Concentration risk — Supplier: National Health Investors master lease; Earnings expected to decline ~94% (cyclical peak). Chart setup: Golden cross, above all MAs, RSI 50, MACD bullish. Prior stop was $159.28. Score 4.9/10, high confidence.

What is the NHC stock price target?

Take-profit target: $180.40 (+5.3% upside). Prior stop was $159.28. Stop-loss: $159.28.

What are the risks of investing in NHC?

Concentration risk — Supplier: National Health Investors master lease; Earnings expected to decline ~94% (cyclical peak); Leverage penalty (D/E 8.1): -1.5.

Is NHC overvalued or undervalued?

National HealthCare Corporation trades at a P/E of 22.8 (forward 407.1). TrendMatrix value score: 5.8/10. Verdict: Sell.

0
What does National HealthCare Corporation do?National HealthCare Corporation operates 80 skilled nursing facilities, 26 assisted living, 9 independent living, 3...

National HealthCare Corporation operates 80 skilled nursing facilities, 26 assisted living, 9 independent living, 3 behavioral health hospitals, and 67 homecare/hospice agencies in 9 states, primarily in the Southeast and Midwest US. Net patient revenues represent 96.8% of operating revenues, with Medicare, Medicaid, and private pay as key sources.

Related stocks: AVAH (Aveanna Healthcare Holdings Inc) · ADUS (Addus HomeCare Corporation) · ASTH (Astrana Health Inc.) · CON (Concentra Group Holdings Parent) · UHS (Universal Health Services, Inc.)